Article
A signature of estimate-stromal-immune score-based genes associated with the prognosis of lung adenocarcinoma
1 Mar 2021
Abstract excerpt
BACKGROUND: Immune and stromal component evaluation is necessary to establish accurate prognostic markers for the prediction of clinical outcomes in lung adenocarcinoma (LUAD). We aimed to develop a gene signature based on the Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data (ESTIMATE)-stromal-immune score in LUAD. METHODS: The transcriptomic profiles of patients with LUAD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
